Wan SC - Search Results

1

NLRP3 in tumor-associated macrophages predicts a poor prognosis and promotes tumor growth in head and neck squamous cell carcinoma.

Chen L, Wan SC, Mao L, Huang CF, Bu LL, Sun ZJ. Chen L, et al. Among authors: wan sc. Cancer Immunol Immunother. 2023 Jun;72(6):1647-1660. doi: 10.1007/s00262-022-03357-4. Epub 2022 Dec 31. Cancer Immunol Immunother. 2023. PMID: 36586012 Free PMC article.

2

Prodrug-Based Versatile Nanomedicine for Enhancing Cancer Immunotherapy by Increasing Immunogenic Cell Death.

Bai S, Yang LL, Wang Y, Zhang T, Fu L, Yang S, Wan S, Wang S, Jia D, Li B, Xue P, Kang Y, Sun ZJ, Xu Z. Bai S, et al. Small. 2020 May;16(19):e2000214. doi: 10.1002/smll.202000214. Epub 2020 Apr 20. Small. 2020. PMID: 32309900

3

Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma.

Wang XL, Wang S, Wu ZZ, Yang QC, Li H, Xiong HG, Wan SC, Sun ZJ. Wang XL, et al. Among authors: wan sc. Int J Med Sci. 2020 Jun 27;17(11):1598-1609. doi: 10.7150/ijms.46809. eCollection 2020. Int J Med Sci. 2020. PMID: 32669963 Free PMC article.

4

Overexpression of PREX1 in oral squamous cell carcinoma indicates poor prognosis.

Wan SC, Wu H, Li H, Deng WW, Xiao Y, Wu CC, Yang LL, Zhang WF, Sun ZJ. Wan SC, et al. J Mol Histol. 2020 Oct;51(5):531-540. doi: 10.1007/s10735-020-09901-9. Epub 2020 Aug 12. J Mol Histol. 2020. PMID: 32785873

5

Overexpression of CD168 is related to poor prognosis in oral squamous cell carcinoma.

Zhu SW, Wang S, Wu ZZ, Yang QC, Chen DR, Wan SC, Sun ZJ. Zhu SW, et al. Among authors: wan sc. Oral Dis. 2022 Mar;28(2):364-372. doi: 10.1111/odi.13766. Epub 2021 Jan 15. Oral Dis. 2022. PMID: 33386685

6

Three-Dimensional Covalent Organic Frameworks with Cross-Linked Pores for Efficient Cancer Immunotherapy.

Zhang L, Yang LL, Wan SC, Yang QC, Xiao Y, Deng H, Sun ZJ. Zhang L, et al. Among authors: wan sc. Nano Lett. 2021 Oct 13;21(19):7979-7988. doi: 10.1021/acs.nanolett.1c02050. Epub 2021 Sep 15. Nano Lett. 2021. PMID: 34525805

7

Engineering Multienzyme-Mimicking Covalent Organic Frameworks as Pyroptosis Inducers for Boosting Antitumor Immunity.

Zhang L, Yang QC, Wang S, Xiao Y, Wan SC, Deng H, Sun ZJ. Zhang L, et al. Among authors: wan sc. Adv Mater. 2022 Apr;34(13):e2108174. doi: 10.1002/adma.202108174. Epub 2022 Feb 15. Adv Mater. 2022. PMID: 34918837

8

GSDME Is Related to Prognosis and Response to Chemotherapy in Oral Cancer.

Wang S, Zhang MJ, Wu ZZ, Zhu SW, Wan SC, Zhang BX, Yang QC, Xiao Y, Chen L, Sun ZJ. Wang S, et al. Among authors: wan sc. J Dent Res. 2022 Jul;101(7):848-858. doi: 10.1177/00220345211073072. Epub 2022 Feb 11. J Dent Res. 2022. PMID: 35148659

9

pH-responsive nanoprodrugs combining a Src inhibitor and chemotherapy to potentiate antitumor immunity via pyroptosis in head and neck cancer.

Zhu SW, Ye M, Ma X, Wu ZZ, Wan SC, Yang SC, Li H, Xu Z, Sun ZJ. Zhu SW, et al. Among authors: wan sc. Acta Biomater. 2022 Dec;154:497-509. doi: 10.1016/j.actbio.2022.10.051. Epub 2022 Oct 29. Acta Biomater. 2022. PMID: 36367476

10

Diselenide-Based Dual-Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer Immunotherapy.

Wan SC, Ye MJ, Yang QC, Zhang T, Zhang MJ, Ma XB, Xu JM, Wang S, Wu ZZ, Yang LL, Shen XM, Xu Z, Sun ZJ. Wan SC, et al. Adv Healthc Mater. 2023 Mar;12(7):e2202135. doi: 10.1002/adhm.202202135. Epub 2022 Dec 11. Adv Healthc Mater. 2023. PMID: 36479643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters